Bruce Chandler May

US Patent:

20130085124, Apr 4, 2013

Filed:

Jun 15, 2011

Appl. No.:

13/704589

Inventors:

Bruce Chandler May - Santa Barbara CA, US

International Classification:

A61K 31/495
A61K 31/56
A61K 31/47

US Classification:

514171, 51425504

Abstract:

The embodiments described herein include methods and formulations for treating influenza, common cold and associated acute inflammation. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.

US Patent:

20200323843, Oct 15, 2020

Filed:

Jun 4, 2020

Appl. No.:

16/893229

Inventors:

- Santa Barbara CA, US
Bruce Chandler May - Santa Barbara CA, US

International Classification:

A61K 31/495
A61K 45/06
A61K 31/47
A61K 31/56

Abstract:

The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient. The combination can be useful during and following radiation exposure to ameliorate the inflammatory response.

US Patent:

20200101067, Apr 2, 2020

Filed:

Sep 30, 2019

Appl. No.:

16/587818

Inventors:

- Santa Barbara CA, US
Bruce Chandler May - Santa Barbara CA, US

International Classification:

A61K 31/495
A61K 33/00
A61K 33/14
A61K 31/57
A61K 31/137
A61K 45/06
A61K 31/341
A61K 31/4164
A61K 31/47

Abstract:

The embodiments described herein include methods and formulations for treating anaphylaxis and related acute allergic reactions. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.

US Patent:

20190298714, Oct 3, 2019

Filed:

Apr 11, 2019

Appl. No.:

16/382077

Inventors:

- Santa Barbara CA, US
Bruce Chandler May - Santa Barbara CA, US

International Classification:

A61K 31/495
A61K 45/06
A61K 31/56
A61K 31/47

Abstract:

The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient. The combination can be useful during and following radiation exposure to ameliorate the inflammatory response.

US Patent:

20190201392, Jul 4, 2019

Filed:

Dec 18, 2018

Appl. No.:

16/224129

Inventors:

- Santa Barbara CA, US
Bruce Chandler May - Santa Barbara CA, US

International Classification:

A61K 31/495
A61K 31/573
A61K 31/519
A61K 31/47
A61K 31/454
A61K 38/19
A61K 31/496
A61K 31/135
A61K 31/4985
A61K 31/136

Abstract:

The embodiments described herein include methods and formulations for treating autoimmune disorders. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.

US Patent:

20190201393, Jul 4, 2019

Filed:

Dec 18, 2018

Appl. No.:

16/224573

Inventors:

- Santa Barbara CA, US
Bruce Chandler May - Santa Barbara CA, US

International Classification:

A61K 31/495
A61P 25/00
A61P 25/28
A61K 45/06
A61P 25/16
A61K 31/47

Abstract:

The embodiments described herein include methods and formulations for treating viruses and diseases that are exacerbated by inflammatory responses in the body. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.

US Patent:

20190091218, Mar 28, 2019

Filed:

Nov 21, 2018

Appl. No.:

16/198544

Inventors:

- Santa Barbara CA, US
Bruce Chandler May - Santa Barbara CA, US

International Classification:

A61K 31/495
A61K 31/47
A61K 45/06
A61K 9/00

Abstract:

Certain embodiments described herein include methods and formulations for treating or preventing symptoms and conditions associated with exposure to ionizing radiation and/or radiation generally. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.

US Patent:

20180185357, Jul 5, 2018

Filed:

Feb 28, 2018

Appl. No.:

15/908387

Inventors:

- Santa Barbara CA, US
Bruce Chandler May - Santa Barbara CA, US

International Classification:

A61K 31/495
A61K 45/06
A61K 38/14
A61K 31/7056
A61K 31/7052
A61K 31/65
A61K 31/635
A61K 31/546
A61K 31/407
A61K 31/424
A61K 31/43
A61K 31/431
A61K 31/47
A61K 31/496
A61K 31/505
A61K 31/5383

Abstract:

The embodiments described herein include methods and formulations for treating lung and brain injury. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.